Recurrent peritoneal serous carcinoma that was unmanageable with paclitaxel–carboplatin therapy responded to autologous formalin-fixed tumor vaccine

Paclitaxel–carboplatin therapy (TC) usually controls primary peritoneal serous carcinoma (PPSC) but not recurrent disease. In this case, PPSC recurred after three courses of TC, responded dramatically to additional autologous formalin-fixed tumor vaccine (AFTV), and resulted in prolonged, progressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jui-Tung, Ohno, Tadao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614649/
https://www.ncbi.nlm.nih.gov/pubmed/26509016
http://dx.doi.org/10.1002/ccr3.353
_version_ 1782396418104754176
author Chen, Jui-Tung
Ohno, Tadao
author_facet Chen, Jui-Tung
Ohno, Tadao
author_sort Chen, Jui-Tung
collection PubMed
description Paclitaxel–carboplatin therapy (TC) usually controls primary peritoneal serous carcinoma (PPSC) but not recurrent disease. In this case, PPSC recurred after three courses of TC, responded dramatically to additional autologous formalin-fixed tumor vaccine (AFTV), and resulted in prolonged, progression-free survival without visible lesions detected by positron emission tomography–computed tomography.
format Online
Article
Text
id pubmed-4614649
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-46146492015-10-27 Recurrent peritoneal serous carcinoma that was unmanageable with paclitaxel–carboplatin therapy responded to autologous formalin-fixed tumor vaccine Chen, Jui-Tung Ohno, Tadao Clin Case Rep Case Reports Paclitaxel–carboplatin therapy (TC) usually controls primary peritoneal serous carcinoma (PPSC) but not recurrent disease. In this case, PPSC recurred after three courses of TC, responded dramatically to additional autologous formalin-fixed tumor vaccine (AFTV), and resulted in prolonged, progression-free survival without visible lesions detected by positron emission tomography–computed tomography. John Wiley & Sons, Ltd 2015-10 2015-09-02 /pmc/articles/PMC4614649/ /pubmed/26509016 http://dx.doi.org/10.1002/ccr3.353 Text en © 2015 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Chen, Jui-Tung
Ohno, Tadao
Recurrent peritoneal serous carcinoma that was unmanageable with paclitaxel–carboplatin therapy responded to autologous formalin-fixed tumor vaccine
title Recurrent peritoneal serous carcinoma that was unmanageable with paclitaxel–carboplatin therapy responded to autologous formalin-fixed tumor vaccine
title_full Recurrent peritoneal serous carcinoma that was unmanageable with paclitaxel–carboplatin therapy responded to autologous formalin-fixed tumor vaccine
title_fullStr Recurrent peritoneal serous carcinoma that was unmanageable with paclitaxel–carboplatin therapy responded to autologous formalin-fixed tumor vaccine
title_full_unstemmed Recurrent peritoneal serous carcinoma that was unmanageable with paclitaxel–carboplatin therapy responded to autologous formalin-fixed tumor vaccine
title_short Recurrent peritoneal serous carcinoma that was unmanageable with paclitaxel–carboplatin therapy responded to autologous formalin-fixed tumor vaccine
title_sort recurrent peritoneal serous carcinoma that was unmanageable with paclitaxel–carboplatin therapy responded to autologous formalin-fixed tumor vaccine
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614649/
https://www.ncbi.nlm.nih.gov/pubmed/26509016
http://dx.doi.org/10.1002/ccr3.353
work_keys_str_mv AT chenjuitung recurrentperitonealserouscarcinomathatwasunmanageablewithpaclitaxelcarboplatintherapyrespondedtoautologousformalinfixedtumorvaccine
AT ohnotadao recurrentperitonealserouscarcinomathatwasunmanageablewithpaclitaxelcarboplatintherapyrespondedtoautologousformalinfixedtumorvaccine

Ejemplares similares